Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 34 checked references that resolve
resolves10.1002/path.1711760307The sequential accumulation of genetic alterations characteristic of the colorectal adenoma–carcinoma sequence does not occur between gastric adenoma and adenocarcinoma
resolves10.3748/wjg.v9.i4.655Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability
resolves10.1002/path.1170Distinct promoter hypermethylation of <i>p</i>16<sup><i>INK</i>4<i>a</i></sup>, <i>CDH1</i>, and <i>RAR‐beta</i> in intestinal, diffuse–adherent, and diffuse–scattered type gastric carcinomas
resolves10.1016/S0140-6736(10)61121-XTrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
resolves10.1074/jbc.M010802200Cloning and Expression of a Novel Nuclear Matrix-associated Protein That Is Regulated during the Retinoic Acid-induced Neuronal Differentiation
resolves10.4161/cc.5.22.3500Role of L2DTL, Cell Cycle-Regulated Nuclear and Centrosome Protein, in Aggressive HepatocellularCarcinoma
resolves10.1038/onc.2008.186Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells
resolves10.1038/onc.2011.3171q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma
resolves10.4161/cc.5.15.3150L2DTL/CDT2 and PCNA Interact with p53 and Regulate p53 Polyubiquitination and Protein Stability through MDM2 and CUL4A/DDB1 Complexes
resolves10.1038/sj.bjc.6605202Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer
resolves10.4161/cc.5.15.3149L2DTL/CDT2 Interacts with the CUL4/DDB1 Complex and PCNA and Regulates CDT1 Proteolysis in Response to DNA Damage
resolves10.1101/gad.1482106DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint
resolves10.1016/j.molcel.2006.08.010A Family of Diverse Cul4-Ddb1-Interacting Proteins Includes Cdt2, which Is Required for S Phase Destruction of the Replication Factor Cdt1
resolves10.1074/jbc.C113.505586Degradation of p12 Subunit by CRL4Cdt2 E3 Ligase Inhibits Fork Progression after DNA Damage
resolves10.1101/gad.1676108PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4<sup>Cdt2</sup> ubiquitin ligase complex
resolves10.1074/jbc.M806045200CDK Inhibitor p21 Is Degraded by a Proliferating Cell Nuclear Antigen-coupled Cul4-DDB1Cdt2 Pathway during S Phase and after UV Irradiation
resolves10.1101/gad.1703708The CRL4<sup>Cdt2</sup> ubiquitin ligase targets the degradation of p21<sup>Cip1</sup> to control replication licensing
resolves10.1083/jcb.201009076SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation
resolves10.1016/j.molcel.2010.10.011Regulation of the Histone H4 Monomethylase PR-Set7 by CRL4Cdt2-Mediated PCNA-Dependent Degradation during DNA Damage
resolves10.1016/j.molcel.2010.09.015CRL4Cdt2-Mediated Destruction of the Histone Methyltransferase Set8 Prevents Premature Chromatin Compaction in S Phase
resolves10.1074/jbc.M111.290767The Stability of Histone Acetyltransferase General Control Non-derepressible (Gcn) 5 Is Regulated by Cullin4-RING E3 Ubiquitin Ligase
resolves10.1093/carcin/bgp116Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma
resolves10.1038/bjc.2013.65Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma
resolves10.1016/j.canlet.2007.12.008Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers
resolves10.1007/s12282-008-0032-5Individualization of breast cancer based on histopathological features and molecular alterations
resolves10.1038/bjc.2014.543Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
checked 2026-07-25 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.